Diurnal Ramadan Fasting on Appetite Hormone and Metabolic Profile Among Lean, Obesity, Diabetics

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

45 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-03-01

Study Completion Date

2021-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Diabetes Mellitus individuals are known to have dietary rules, namely regulating the amount, type and time of eating. Ramadan fasting seems to be beneficial for people who want to reduce their weight, but it is not easy for diabetic patients. Because of its distinctive features, Ramadhan induces changes in eating habits, calorie consumption, sleeping patterns, and daily physical activity, which may contribute to changes in hunger-satiety responses and glicemic control. Examining changes in gut hormones during Ramadan fasting may reveal whether this observance could change glucose metabolism in diabetics without triggering the undesirable effect of gluconeogenesis. The proportions of fat, protein, and carbohydrate in meals vary between outside and within Ramadan. Alterations in timing and composition meal during Ramadan lead to reduced food intake may affect gut hormones and metabolic responses. The aim of this study to determine whether the effect of Ramadan fasting differed in people with DM patients, pre-DM and healthy individuals, with respect to gut hormones, body composition, metabolic parameters, and glycemic control

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Alteration in Body Composition and Metabolic Profile During Ramadan Fasting in Healthy Men

NCT03098381

Fasting

COMPLETED

The Effect of Fasting on Serum Osmolarity in Diabetic Patients

NCT04392570

Type2 Diabetes

COMPLETED

Prolonged Fasting on Glucose Metabolism and Hormonal Regulation in Healthy, Obese and Subjects With Type 2 Diabetes

NCT04283318

Healthy Obesity Type 2 Diabetes Mellitus +1 more

COMPLETED NA

Monday is Fasting Day - Non-Randomized Trial on Intermittent Fasting

NCT02253056

Healthy Volunteers

COMPLETED NA

Effect of Intermittent Fasting (Month of Ramadan) on Health

NCT05571891

Fasting, Intermittent

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The experimental study was performed during and after Ramadan fasting in 2021 (April to May) in Semarang, Indonesia. The present study was performed using the quasy-experimental method by pre-post measurement of three experimental groups (diabetics, Obese and healthy subjects) selected using the purposive sampling methods

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fasting Gut Hormone

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

three arm parallel group with 45 subjects:

1. fasting in lean group
2. fasting in obese group
3. fasting in diabetics group

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

subject with random allocation Investigator do not know the group the analysator do not know the group

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

lean ramadan fasting

conduct ramadan fasting for 30 days

Group Type EXPERIMENTAL

diurnal fasting

Intervention Type BEHAVIORAL

subject conduct fasting in Ramadan for 30 days

obese ramadan fasting

conduct ramadan fasting for 30 days

Group Type EXPERIMENTAL

diurnal fasting

Intervention Type BEHAVIORAL

subject conduct fasting in Ramadan for 30 days

diabetics ramadan fasting

conduct ramadan fasting for 30 days

Group Type EXPERIMENTAL

diurnal fasting

Intervention Type BEHAVIORAL

subject conduct fasting in Ramadan for 30 days

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

diurnal fasting

subject conduct fasting in Ramadan for 30 days

Intervention Type BEHAVIORAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

ramadan fasting

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diabetics subjects: glucose fasting plasma \> 200 mg/dL, with aged 35-60 years and body mass index above 25 kg/m;
* Obese subjects: body mass index above 25 kg/m2 with aged 35-60 years and waist circumference for men \>90 cm, for women \> 80 cm
* Lean subjects: body mass index below 23.5 kg/m2 with aged 35-60 years and waist circumference for men \<90 cm, for women \< 80 cm

Exclusion Criteria

* experienced weight loss more than 10% from the actual weight in the last three months
* consumed medicine or supplement for weight loss diet, •. had the history of evidence of clinical depression, cognitive disorders, heart disease, cancer, liver or renal disease, chronic pulmonary disease, uncontrolled hypertension, physical disability, or other contraindications

Minimum Eligible Age

35 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No